Goldman Sachs maintained a Neutral rating on Gilead Sciences (NASDAQ: GILD) and raised its price target to $59.00 (from $54.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View

Baird Downgrades Gilead Sciences (GILD) to NeutralJuly 26, 2013 10:03 AM Atlantic Equities Upgrades Gilead Sciences (GILD) to OverweightJuly 26, 2013 7:59 AM Gilead Sciences, Inc. (GILD) Reports In-Line Q2 EPSJuly 25, 2013 4:07 PM